Bon Natural Life Limited Class A Ordinary Shares (BON) Stock Price

BONStock

$1.14−46.92%52W

Market Cap$9.28M

P/E—

PEG Ratio—

Div yield—

Beta-0.22

BON Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.84%

Price vs S&P 500 (4W)-4.64%

VGM Score58.51

P/CF (Annual)65.75x

Book Value / Share (Quarterly)$6.22

P/TBV (Annual)0.24x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-14.54%

Cash Flow / Share (Quarterly)$-0.42

Price vs S&P 500 (YTD)-40.49%

Gross Margin (TTM)22.10%

Net Profit Margin (TTM)-60.39%

EPS (TTM)$-1.93

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-1.93

Revenue Growth (5Y)0.49%

EPS (Annual)$-0.72

ROI (Annual)-2.86%

Gross Margin (Annual)20.77%

Net Profit Margin (5Y Avg)9.08%

Cash / Share (Quarterly)$0.71

Revenue Growth QoQ (YoY)1.86%

ROA (Last FY)-2.34%

Revenue Growth TTM (YoY)-12.92%

EBITD / Share (TTM)$-1.62

ROE (5Y Avg)9.83%

Operating Margin (TTM)-55.40%

Cash Flow / Share (Annual)$-1.21

P/B Ratio0.18x

P/B Ratio (Quarterly)0.16x

Net Income / Employee (Annual)$-20,800

EV / Revenue (TTM)0.83x

Net Interest Coverage (TTM)-3.68x

ROA (TTM)-13.74%

EV / EBITDA (TTM)5.04x

EPS Incl Extra (Annual)$-0.72

Current Ratio (Annual)1.74x

Quick Ratio (Quarterly)1.09x

3-Month Avg Trading Volume0.01M

52-Week Price Return-46.92%

EV / Free Cash Flow (Annual)5.38x

Revenue / Employee (TTM)$196,000

Tangible BV / Share (Quarterly)$5.43

P/S Ratio (Annual)0.50x

Asset Turnover (Annual)0.22x

52-Week High$2.25

Operating Margin (5Y Avg)12.45%

EPS Excl Extra (Annual)$-0.72

CapEx CAGR (5Y)18.20%

26-Week Price Return-11.94%

Quick Ratio (Annual)1.28x

13-Week Price Return-2.08%

Total Debt / Equity (Annual)0.21x

Current Ratio (Quarterly)1.83x

Enterprise Value$15.67M

Revenue / Share Growth (5Y)-21.53%

Asset Turnover (TTM)0.23x

Revenue / Employee (Annual)$194,500

Inventory Turnover (Annual)6.07x

Pretax Margin (Annual)-9.16%

Cash / Share (Annual)$0.46

3-Month Return Std Dev41.21%

Gross Margin (5Y Avg)27.99%

Net Income / Employee (TTM)$-118,400

ROE (Last FY)-3.47%

Net Interest Coverage (Annual)-20.08x

EPS Basic Excl Extra (Annual)$-0.72

P/FCF (TTM)4.32x

Receivables Turnover (TTM)1.78x

EV / Free Cash Flow (TTM)1.87x

Total Debt / Equity (Quarterly)0.24x

EPS Incl Extra (TTM)$-1.93

Receivables Turnover (Annual)1.64x

ROI (TTM)-17.13%

P/S Ratio (TTM)0.49x

Pretax Margin (5Y Avg)11.81%

Revenue / Share (Annual)$6.78

Tangible BV / Share (Annual)$6.29

Forward P/E2.09x

Price vs S&P 500 (52W)-62.45%

EPS Growth TTM (YoY)-96.73%

Year-to-Date Return-28.56%

5-Day Price Return0.65%

EPS Normalized (Annual)$-0.72

ROA (5Y Avg)7.50%

Net Profit Margin (Annual)-10.68%

Month-to-Date Return-5.34%

Cash Flow / Share (TTM)$0.71

EBITD / Share (Annual)$-0.19

Operating Margin (Annual)-8.69%

LT Debt / Equity (Annual)0.01x

P/CF (TTM)0.85x

ROI (5Y Avg)8.74%

LT Debt / Equity (Quarterly)0.03x

EPS Basic Excl Extra (TTM)$-1.93

P/TBV (Quarterly)0.18x

P/B Ratio (Annual)0.21x

Inventory Turnover (TTM)4.58x

Pretax Margin (TTM)-59.66%

Book Value / Share (Annual)$7.08

Price vs S&P 500 (13W)-4.76%

Beta-0.22x

P/FCF (Annual)310.33x

Revenue / Share (TTM)$3.09

ROE (TTM)-20.98%

52-Week Low$0.95

vGradeA

gGradeD

mGradeC

vgmGradeC

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About Bon Natural Life Limited Class A Ordinary Shares

Bon Natural Life Ltd manufactures natural personal care and health ingredients, primarily plant-extracted fragrance compounds for cosmetic applications, along with natural health supplements and bioactive food ingredients. The company has developed proprietary technology platforms for extraction, safety enhancement, and functional compounding of natural products. Revenue is primarily derived from fragrance compound sales to perfume and cosmetic manufacturers, with additional revenue from supplement and food ingredient customers.